The goals of the Biochemistry and Pathology Core, are two-fold: First, the Biochemistry Unit of the Core will serve to perform assays on tissues/plasma of mice and cultured cells studied in the individual projects, including assessment of 4-hydroxynonenal, malondialdehyde, nitric oxide, 3-deoxyglucosone, diacylglycerol, and activities of superoxide dismutase (CuZn SOD and MnSOD), aconitase, aldose reductase, sorbitol dehydrogenase and Protein Kinase C. This unit will be led by Dr. Ravichandran Ramasamy, an experienced biochemist whose laboratory routinely performs these analyses; extensive quality control measures and equipment maintenance/rapair are in place in order to ensure consistency of results across the projects. Second, the Pathology Unit of this Core will serve to perform pathologic analyses of mouse hearts, aortae en face, innominate arteries, and aortic sinus, as well as routine immunohistory with semi-quantitative analysis of extent/intensity of immunostaining. This unit will be led by Dr. Vivette D'Agati, who is a long-time collaborator of the Principle Investigator of the Program Project. The biochemical and pathologic analysis of tissues is best done under the auspices of a core unit in order to ensure consistency of sample preparation, assay performance and quantitative analysis. The Biochemistry and Pathology Core wioll serve all three projects of the Program during each of the five years of the Program Project Grant.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL060901-08
Application #
7280395
Study Section
Heart, Lung, and Blood Initial Review Group (HLBP)
Project Start
Project End
Budget Start
2006-09-01
Budget End
2007-08-31
Support Year
8
Fiscal Year
2006
Total Cost
$141,960
Indirect Cost
Name
Columbia University (N.Y.)
Department
Type
DUNS #
621889815
City
New York
State
NY
Country
United States
Zip Code
10032
Schmidt, Ann Marie (2018) Highlighting Diabetes Mellitus: The Epidemic Continues. Arterioscler Thromb Vasc Biol 38:e1-e8
Lee, Gloria; Plaksin, Joseph; Ramasamy, Ravichandran et al. (2018) Targeted drug discovery and development, from molecular signaling to the global market: an educational program at New York University, 5-year metrics. J Transl Sci 4:1-9
Lee, Gloria; Kranzler, Jay D; Ramasamy, Ravichandran et al. (2018) Training scientists as future industry leaders: teaching translational science from an industry executive's perspective. J Transl Sci 4:
Schmidt, Ann Marie (2017) 2016ATVBPlenary Lecture: Receptor for Advanced Glycation Endproducts and Implications for the Pathogenesis an Treatment of Cardiometabolic Disorders: Spotlight on the Macrophage. Arterioscler Thromb Vasc Biol 37:613-621
López-Díez, Raquel; Shen, Xiaoping; Daffu, Gurdip et al. (2017) Ager Deletion Enhances Ischemic Muscle Inflammation, Angiogenesis, and Blood Flow Recovery in Diabetic Mice. Arterioscler Thromb Vasc Biol 37:1536-1547
Shekhtman, Alexander; Ramasamy, Ravichandran; Schmidt, Ann Marie (2017) Glycation & the RAGE axis: targeting signal transduction through DIAPH1. Expert Rev Proteomics 14:147-156
Senatus, Laura M; Schmidt, Ann Marie (2017) The AGE-RAGE Axis: Implications for Age-Associated Arterial Diseases. Front Genet 8:187
López-Díez, Raquel; Shekhtman, Alexander; Ramasamy, Ravichandran et al. (2016) Cellular mechanisms and consequences of glycation in atherosclerosis and obesity. Biochim Biophys Acta 1862:2244-2252
Thiagarajan, Devi; Vedantham, Srinivasan; Ananthakrishnan, Radha et al. (2016) Mechanisms of transcription factor acetylation and consequences in hearts. Biochim Biophys Acta 1862:2221-2231
Manigrasso, Michaele B; Pan, Jinhong; Rai, Vivek et al. (2016) Small Molecule Inhibition of Ligand-Stimulated RAGE-DIAPH1 Signal Transduction. Sci Rep 6:22450

Showing the most recent 10 out of 78 publications